针对癌症中的铁亡的天然产品:分子机制和应用
1Department of Pathology, Danyang Hospital of Traditional Chinese Medicine, Zhenjiang, Jiangsu, China.
Frontiers in oncology
|September 25, 2025
概括
铁亡,一种与癌症相关的细胞死亡途径,可以由天然产品诱导. 这篇评论探讨了像黄类药物这样的天然化合物如何针对癌症治疗的铁亡,为化学诱导剂提供了低毒性的替代品.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 药理学 药理学 是一个学科.
背景情况:
- 铁亡是由铁和脂质过氧化驱动的受程序细胞死亡,涉及各种癌症.
- 目前的铁灭诱导剂 (小分子) 显示有毒性,限制了临床使用.
- 天然产品为癌症治疗提供了低毒性的方法.
研究的目的:
- 审查铁灭的分子机制.
- 分析针对铁亡途径的自然产品如何影响瘤生长.
- 讨论自然产品在诱导癌细胞中的铁亡中的应用.
主要方法:
- 关于铁亡机制的文献综述.
- 对自然产品 (黄类,类,类) 和铁灭菌的研究分析.
- 评估天然产品在诱导瘤细胞中的铁亡的疗效.
主要成果:
- 自然产品可以诱导瘤细胞中的铁亡,这是一种有前途的治疗策略.
- 具体的自然产品类别,包括黄类,类和类,显示出潜在的潜力.
- 通过天然产品诱导铁死,为合成诱导剂提供了更安全的替代方案.
结论:
- 天然产品代表了针对癌症治疗中的铁亡的可行和不那么有毒的选择.
- 对天然产品衍生的铁灭诱导剂的进一步研究对于临床应用是有必要的.
- 这一审查有助于发现基于铁灭的癌症治疗的新型天然产品.
相关概念视频
Necrosis
6.3K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.3K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Drugs that Destabilize Microtubules
3.6K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
